Hedgehog drugs begin to show results.
Garber
Ken
K
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D001847:Bone Diseases / Q000139:chemically induced; D001842:Bone and Bones / Q000187:drug effects*; D001932:Brain Neoplasms / Q000188:drug therapy; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D008527:Medulloblastoma / Q000188:drug therapy; D015513:Oncogene Proteins / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects*; D012878:Skin Neoplasms / Q000188:drug therapy; D015534:Trans-Activators / Q000037:antagonists & inhibitors*; D000071676:Zinc Finger Protein GLI1
D000970:Antineoplastic Agents; D053823:Hedgehog Proteins; D015513:Oncogene Proteins; D015534:Trans-Activators; D000071676:Zinc Finger Protein GLI1